News | Women's Health | October 08, 2021

An analysis of nearly 200,000 patients highlights the heterogeneity of breast cancer risk factors for women of differing races, ages, and disease subtypes

An analysis of nearly 200,000 patients highlights the heterogeneity of breast cancer risk factors for women of differing races, ages, and disease subtypes

Getty Images


October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S. health systems underscores the importance of understanding the heterogeneity of breast cancer risk factors for women of differing races, ages, and disease subtypes. The study, led by researchers in the Perelman School of Medicine at the University of Pennsylvania, were published in Cancer Medicine.

The cohort included 29,822 (15 percent) Black women — a group historically understudied in cancer research. Most strikingly, the researchers found that Black women had nearly a three-fold increased risk of triple negative breast cancers, which have a poor prognosis. While it is known that Black women have a higher risk of this type of breast cancer, the magnitude of the risk found in this study was impactful, given its comprehensive adjustment for breast cancer risk factors in a screened population.

Additionally, the researchers found that triple negative breast cancers were less likely to be screen detected and more likely than other subtypes to be diagnosed as interval cancers. Higher breast density was associated with increased risk of all four tumor subtypes, with a stronger association among premenopausal women for ER/PR+HER2- and TNBC.

In a separate study led by the same group, the researchers looked further at risk factor among Black women. They found that breast density was more strongly associated with TNBC than other subtypes, and obesity was associated with greater risk of TNBC among this group. Those findings were published in Breast Cancer Research and Treatment.

“The risk prediction models available are about 60 percent accurate for predicting risk of breast cancer,” said Anne Marie McCarthy, PhD, an assistant professor of Epidemiology at Penn. “In our studies, we see clear differences in risk factors across these types of breast cancers, and we need to do a better job of identifying how we can accurately predict risk for women, particularly for women of color.”

For more information: www.pennmedicine.org

Related Breast Imaging Information:

Black Women Are Receiving Inferior Breast Screening

Hologic Partners with Oprah Winfrey Network to Combat Health Disparities for Black Women

Legislation May Help Identify Breast Cancer Earlier in Certain At-risk Women

Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide

Johns Hopkins Medicine Expert Weighs Devastating Impact of COVID-19 on Healthcare Workers

Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

Breast Imaging in the Age of Coronavirus


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
Subscribe Now